Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stockholm Diabetes Intervention Study
NCT02138006Completed
- Sponsor
- Karolinska Institutet
- Start
- Sep 1982
- Primary completion
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of human insulin in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Cardiovascular Mortality at 28 years. Started Sep 1982; status: completed.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02138006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02138006.